Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jun 27, 2008

Millipore Completes $3.4M Expansion of Missouri Facility

  • Millipore opened the $3.4 million expansion of its St. Charles, MO, facility, which is the headquarters for its drug discovery business unit. The company plans to hire an additional 60 employees at the St. Charles site, which currently employs 187 people.

    Millipore is seeking LEED certification of the expanded and renovated 17,000 sq. ft. space. This will be the third building on Millipore's 43-acre Missouri Research Park campus. The new area will have laboratories, administrative offices, and an enlarged break area.

    “Our expanded St. Charles facility will help us meet the needs of customers at every stage of the drug discovery and development pipeline, from target identification through clinical studies,” states Rick Ryan, vp of the drug discovery and development business unit.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »